DNA treatment with sensitive and/or dependent restriction enzymes, followed by PCR amplification is a widely used approach for testing CpG methylation. Recently, MspJI has been characterized as a promisory tool for epigenetic analyses. In the present report, we describe that MspJI shows significant activity against non-methylated DNA, suggesting that additional caution and improvements would be required before applying this enzyme as a routine epigenetic tool.
INTRODUCTION
In the last years, research on the epigenetic DNA modification has increased exponentially. In particular, knowing the methylation state of cytosine residues at CpG sites in animal genomes is a widely addressed issue, because 5-methylcytosine has been implied as a major regulatior of gene expression [1] .
Two general basic approacches have been used for detecting cytosine methylation; namely bisulfite conversion and restriction with methylation-sensitive or dependent enzymes. The bisulfite based methods are powerful but cumbersome, since bisulfite modified DNA is unstable, containing many strand breaks, and difficult to amplify. Therefore, restriction based approcches are of choice for non-specialized laboratories.
One of these approaches is based on the combination of genomic DNA restriction with PCR (preferably qPCR) amplification, using primers flanking the DNA region under study [2] (Figure 1 ). Recently, a novel and promisory methyl-dependent enzyme has been described: MspJI [3] . This enzyme has been characterized and described as cleaving the m CNNR sequence, being inactive against non-methylated sequences. For this reason, it has been postulated as a powerful tool for epinegetic studies, being able to detect around 50% of methylated cytosines at CpG sites. Therefore, we tested this enzyme as a tool for the specific detection of cytosine methylation on mammalian genomic DNA. 
METHODS

DNA purification
DNA was purified from mice peritoneal macrophages or G. lamblia axenic cultures using the Wizard® Genomic DNA Purification Kit (Promega), following the manufacturer instructions. Integrity of DNA was confirmed by agarose electrophoresis and quantification was carried out by absorbance at 260 nm using spectrophotometer (BioTek Instruments, Epoch™ /Take3™ Multi-Volume Plate).
Digestion with MspJI
Genomic DNA (1µg) was digested following the manufacturer instructions, using 2 unit of MspJI (New England Biolabs) in the presence of 1 µl double-stranded DNA activator in a 30-µL volume. All reactions were incubated at 37 °C for 4 h or 8 h. The digestion products were visualized on 1% agarose electrophoresis.
End-point PCR
PCR reactions were performed using 50 ng of genomics DNA incubated at 37ºC in the presence or in the absence of MspJI. The following oligonucleotides were designed in order to amplify a 1,799 bp fragment from the IL-12b Fw: 5' TCGGCCCCATATTGCTTTGT 3'
and Rev: 5' ACAGCCTCTAGATGCAGGGA 3'. Thermocycling conditions were as follows;
1 cycle at 94°C for 30 sec; 35 cycles of 94°C for 30 sec, 63°C for 45 sec, 72°C for 2 min ; followed by a final elongation step at 72°C for 10 min. Amplicons were visualized by electrophoresis on 1.5% agarose gel. Figure 2 shows the digestion pattern after incubation of murine genomic DNA with MspJI.
Real-time PCR
RESULTS AND DISCUSSION
As expected, a smeared pattern was observed, consistent with the digestion of a densely methylated DNA. On the other hand, when genomic DNA of the protozoan Giardia lamblia showed a pattern similar to undigested sample. These results are consistent with a highly specific digestion of methyled DNA by MspJI, according to previous reports. Next, we used MspJI digested mice DNA as template to amplify a 1,799 bp fragment from the IL-12b gene (GenBank: AH004859) (nt -1693bp to +106 bp, numbers according to the transcription initiation site), containing 39 CpG sites. Notably, digestion with MspJI completely prevented the amplification of the selected region, suggesting a high methylation state (Figure 3) . (Figure 4) , showing that DNA degradation was not dependent on CpG methylation.
Although this would be rather unusual, it can be postulated that methylated cytosines at sequences other than CpG were present in the genomic samples and recognized by MspJI. In fact, it has been reported non-CpG methylation in stem cells and, more recently, in differentiated mammalian cells [4] . Therefore, in order to evaluate the specificity of the assay using a bona fide non-methylated sample, we replaced genomic DNA template by a diluted PCR product. Notably, treatment of this non-methylated DNA sample with MspJI, PCR amplification was prevented, definitively confirming that MspJI degrades non-methylated DNA at a significant extension. These results demonstrate that MspJI is inadequate for epigenetic analyses based on methylation-dependent restriction coupled to qPCR strategy (Figure 5) . Concluding, we have found that even when MspJI selectively degrade methylated DNA, its activity against non-methylated DNA is not negligible. Therefore, cautions should be taken when using this enzyme for epigenetic studies.
